qf ± te gil far ffla eta fro q5 rfu a atifa gt wi at · fro fin tit titfft a i qeqt7t fai= fro 1...

4
I I iirTRE th FErfu froz3Trf.a.qu.tft. z202O z 7jo in, ffro o8 z06 z202O rfu' 1. H7]RI thTTTha eriIr, FErfu I 2. HqRI fin i5aifET, iTe4rfu I 3. HqtiT gel fafin Tj tiTma 3Tfan, qtwh I fin:- ae-19 tiffiTIT ts qfleror te tRT Hffi aTqfan 8itT tF ffi fan ch a ffi fi I wh:-(1) rfu, q]iifi ffliq7TT, tiiT¥zT ti qfir q5ffliuT fairm i3iffl q5T qT ffro 12.05.2020 (2) 3TTIr, HTRI an tFT qi* fro/DHs;IDsp;2020;7i2 ffro 28.05.2020 ---00--- Bqha rat]iimitci ffi qfi tS tiiit]H # 3]t]iiiT t5iitIT fflFT a fai rfu S f`RT flT]H Hq`iii¥iicti¥., ch ae-19 fl3FTTUT t} ha q5T qfle]uT ed te 3]fty €, ch faim aitT TF fiqfan fan ch te fRE fin iit]T g I BTha fa- fan EiiT qF tiqfen fan ul # €IT i ri+i5{il< rfu 3TqTrf ch tfl aqqTen 5fffi @ tilt :- 1. 3Trf.th.qu.37TT., rm iTFT tft iilsc€cii€ci 3TFT tRT tiffl 5T chri ¥ qfr wh rd qi it3FT ffl tREtfan ie 20;0 a 50;0 tFT a I 50;0 d 3Tfha `rfiti€iit]€\ ie dr fi IcMR IHSc5cii€ti 3T5uiT RT-PCR fro fl fan wh 3TerfeT 5% ar Ewl a 3Tfha uiruic^Ic^Iic^i dr S TF © ffiha g I 2. qF tiTh ed 5T rfu tFF ij3FT nd an # Hfich ZFT tlBE" i fife-19 a tt3rm at R¥7a gitT tFii]T a, fas fir q5iife chri a 3]enqT qtF¥ chfi a dr iiir`uic^Irac^i 50;0 ti tFTT €, ti gr tiTqfan tfl ffl di € I 3. TF tiTffl ted s far ET an E di Fxp/gran TrTof (th.3TE.vH.w. t} 5trm)/gil 3ftT ttfira EB tltiii]/fffl ch/3ifeife dr ti 5iTT tFvi nd qiHiF;i]TR fin Ta qiiT qifin t} ofrfu/tlrdrfu qTH rty Tgiv t} aS ETqffl;5q rty ffi nd farfu rty ffi 3TTan fi ed qTa dr Eat q5T fro fin TIT titFFT a I qEqt7T fai= fro 1 3T=tliT ICMR IIisc€ct[Eti tFT qTai] Fl-RqFT at , fflfiat te qF tiffl a far 3TT±.th.qu.3TTi. EB =iTT fiqifin rfu tPr liistGci|Sr+ a 3Tfaica asymptomatic low risk group t} un fca ffl wh € I qF ± te gil far ffla Eta fro q5 rfu a aTifa gt wi at ;fro ifetFd at;t7ha¥ an fie 3TTfa a fir un giv fro an q@ qF rfu q9maq en I

Upload: others

Post on 21-Jul-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: qF ± te gil far ffla Eta fro q5 rfu a aTifa gt wi at · fro fin TIT titFFT a I qEqt7T fai= fro 1 3T=tliT ICMR IIisc€ct[Eti tFT qTai] Fl-RqFT at , fflfiat te qF tiffl a far 3TT±.th.qu.3TTi

I I iirTRE thFErfu

froz3Trf.a.qu.tft. z202O z 7jo in, ffro o8 z06 z202Orfu'

1. H7]RI thTTTha eriIr, FErfu I2. HqRI fin i5aifET, iTe4rfu I3. HqtiT gel fafin Tj tiTma 3Tfan, qtwh I

fin:- ae-19 tiffiTIT ts qfleror te tRT Hffi aTqfan 8itT tF ffi fan ch affi fi I

wh:-(1) rfu, q]iifi ffliq7TT, tiiT¥zT ti qfir q5ffliuT fairm i3iffl q5T qTffro 12.05.2020

(2) 3TTIr, HTRI an tFT qi* fro/DHs;IDsp;2020;7i2 ffro 28.05.2020---00---

Bqha rat]iimitci ffi qfi tS tiiit]H # 3]t]iiiT t5iitIT fflFT a fai rfu Sf`RT flT]H € Hq`iii¥iicti¥., ch ae-19 fl3FTTUT t} ha q5T qfle]uT ed te3]fty €, ch faim aitT TF fiqfan fan ch te fRE fin iit]T g I

BTha fa- fan EiiT qF tiqfen fan ul # €IT i ri+i5{il< rfu3TqTrf ch tfl aqqTen 5fffi @ tilt :-

1. 3Trf.th.qu.37TT., rm iTFT tft iilsc€cii€ci 3TFT tRT tiffl 5T chri ¥ qfr whrd qi it3FT ffl tREtfan ie 20;0 a 50;0 tFT a I 50;0 d 3Tfha `rfiti€iit]€\ iedr fi IcMR IHSc5cii€ti 3T5uiT RT-PCR fro fl fan wh 3TerfeT 5% ar Ewl a3Tfha uiruic^Ic^Iic^i dr S TF © ffiha g I

2. qF tiTh ed 5T rfu tFF ij3FT nd an # Hfich ZFT tlBE" ifife-19 a tt3rm at R¥7a gitT tFii]T a, fas fir q5iife chri a 3]enqTqtF¥ chfi a dr iiir`uic^Irac^i 50;0 ti tFTT €, ti gr tiTqfan tfl ffl di € I

3. TF tiTffl ted s far ET an E di Fxp/gran TrTof (th.3TE.vH.w. t}5trm)/gil 3ftT ttfira EB tltiii]/fffl ch/3ifeife dr ti 5iTT tFvind qiHiF;i]TR fin Ta qiiT qifin t} ofrfu/tlrdrfu qTH rty Tgiv t}aS ETqffl;5q rty ffi nd farfu rty ffi 3TTan fi ed qTa dr Eat q5Tfro fin TIT titFFT a I qEqt7T fai= fro 1 3T=tliT ICMR IIisc€ct[Eti tFT qTai]

Fl-RqFT at ,

fflfiat te qF tiffl a far 3TT±.th.qu.3TTi. EB =iTT fiqifin rfu tPr liistGci|Sr+a 3Tfaica asymptomatic low risk group t} un fca ffl wh € I

qF ± te gil far ffla Eta fro q5 rfu a aTifa gt wi at;fro ifetFd at;t7ha¥ an fie 3TTfa a fir un giv fro an q@ qFrfu q9maq en I

Page 2: qF ± te gil far ffla Eta fro q5 rfu a aTifa gt wi at · fro fin TIT titFFT a I qEqt7T fai= fro 1 3T=tliT ICMR IIisc€ct[Eti tFT qTai] Fl-RqFT at , fflfiat te qF tiffl a far 3TT±.th.qu.3TTi

iF an ts ft TTa ffi tit Tu.SIR.vtF. If 3TT¥.a.Tft.th,3TR. qu a id qTwhga rm at/t7ha¥ Fife EiiT ife3T@ e]iT wh I TF thrfan a ±f±ETT #qRurm tffiitF 3FTi @ ReTfa ¥ sH gr S tifffi flFRI an qFT T9Tdy-T97tFed EiiT gT: RT-PCR qi ufle7uT fin iFTTiiT I

ca flT]RI fro ch ffro T97tF-T97tF RT.PCR fa aT giiT fin ffl {gT a, q5TICMR ife qT rm at;the Fife EiiT `]iT g3FT ife3T@ qu.3TR.TtF. iqrriaT tit q{ ife TT giv fin wh I Tgr irm # Th 3nT 5a tiqirrii q}jife rm GTTgT I

str{\iqtllt{Thr Ffin ZFT qii]T zed gq qF ± ed 5fr =m fi fai=tlfro at5T Tit5T fin tliT tTan gtFFT at q} qiq fro 03 a 06 ¥ qfife qiin q5THrsE 5tT d rfua]uT fin ¢iv I

TF tiffl ed zfl =m E un fca t} Bq fafin qu qTnI 3Tfen 3;itfin fii±fau\i.tlirqi= an t7g tiTTdi an fa5 a tRT © fca qi.a qTatlTRI an tfr ¥97tF a, wi Tu.TtF.SIR.TtF. trri t} "q fca @ f±r5iffu(fu) H-3ff # ffi at aan HTirTTirm mTTfl aife ed fro in TFRE VI a 3Trm wh I

5qfro t} TRha fi fan HtFiT tfi 3TGTtF qTRE mtFT ed ts ef . 3Tviie rna,fltTTFT, F.ffi.a.ffi. a €-fa arvindrai21 @mail.com 3Te]qT ef. di qlT,

iFird€-harubykhan@mpgov`n:5iREE,gL

FErfu

ggE:£3T#ngTug ,/202Oz 79i qfro, ffrooez06z20201. 3FTT IH ufir, FtFrfu enfflT, ds tii{qu giv qRm q5qiuT fin/f±rfin

fuen fin, i5rTRI in I2. HBE rfu, Ftrfu ¥rmT, as qTvy q pfin q5qipT fin, ri5TTffl fro I3. qBE rfu, FEFrfu enfflT, fafin ftren fin, F5rTffl, afro I4, 3ngr, fafin ftren farm, q€qrfu afro I5. fin tiqTffl, " till:ezT fin, qtrfu, ifro I6. ij€ (3Trf.©.TIT.Tft.) tiTRI ch, qtFrfu I7. flT]ia 3Tfin, fafin TEfitTTRT, 7Itrfu I8. HT]RI an tiFTt]tF, tiiT¥zT an, 7Itrfu I

:o==whaevI_]Fma-#Fde¥ELaney5ffil- - i _ r\: __ \11. ef. 3Tffi rna, iTaii5tFTT, afflTra tiH tFi{ fewi 'qFxp

|EN tifitry, `]iitT tli5ii, * fan 1 10054

fa.q5.3T. HE!{-t+EiqTRI

tfl|<d 3TTtF

#ha.+

Page 3: qF ± te gil far ffla Eta fro q5 rfu a aTifa gt wi at · fro fin TIT titFFT a I qEqt7T fai= fro 1 3T=tliT ICMR IIisc€ct[Eti tFT qTai] Fl-RqFT at , fflfiat te qF tiffl a far 3TT±.th.qu.3TTi

0DIRECTORA" oF HEALTH SERVICES

SATI.UDA nH^w^N , nHop^L, MADHVA PRADE5H

NO ` /DHS/lDSp/2o2o/~+I a_ Bhopal dt.2J705/2020

TO,

1. All Commissioners, MP.

2. All Deans, Govt. Medical college, MP.

3. All ln Charge, Gol Labs (located in MJ2)

Subject: Testing of pooled samples for sARs.cov.2 for surveillance in low risk areas...res/-

Relerence: letter i.rum St:ii cia, y, : :ca!t.L`. & .E3rt`il`,j Welfare, Gal. vide letter no 2.

28015/19/2020/EMR, dated 13.05.2020----yr----

YOur attention is requested on the |CMR Guidelines published for "Testing of

Pooled samples for surveillance in dlfferent low risk zones or communities".

All Govt. labs of MP (both State/Central Govt. labs) are advised to plan parallel

testing of pooled samples ln batches of "pools of 5 samples each" on samples collected

from low risk areas.

while doing so, each of the 5 Samples must be tested individually if a

particular pool is found positive; Without Changing the CT value of raising baselineduring Real time PCR test on Such Samples. All Samples belonging to pools found

negative can be reported NEGATIVE With remark that "Tested Negative in the pooled

protocol of lcMR".

Appropriate direction will be issued for COIIection of Such samples from low risk

zones covering entire Mdci'!iy6 I;.a:CJ.i; :'Jch ::.rT`P!9: `.I,`!!! ±e Ser:t tc ±ecigr::ted ,-.c=rb.,.

labs for Real time PCR testing and reporting.

All labs are requested to gear-uP for Pooled testing along with testing of

individual samples as per the lcMR Guideline.

Attached:-As above

Commissioner,

Health services

M`p`

I(idwai)

Page 4: qF ± te gil far ffla Eta fro q5 rfu a aTifa gt wi at · fro fin TIT titFFT a I qEqt7T fai= fro 1 3T=tliT ICMR IIisc€ct[Eti tFT qTai] Fl-RqFT at , fflfiat te qF tiffl a far 3TT±.th.qu.3TTi

rty--

:£i,E#Sub 14thBf,i

wh

T;+:¢h./¥nionis¢{l/"[l..9..I

tr.a-2-.*t.§..I(-t£...i€be?r,ctng`*S`ts

•:RE*pequ....-"fe..`:

qufty,'f",xp

'ma- vi tit,qqTrty qrf qfu

ooverrmvyl BquLrtmut of deal

ttlfritryyoffflath

2- 6 =1 '}'

i ,,i . ]5.Of;.?C'2t,;`` --`11.~~** ., ~ +6.^:-,'r. ` ^*, , I -` .-`-

rfuiven`i`ife;hfor.,rfuidriof<

rim7Tan

W®lfar®Ji.Ifan,

'? ffiQ2fl

quid¢inas have beeii` 'p¢€Sa*ed on;±g±giir¥fflfarferfurcovihais'x:;an af

on 1'1j5,£020. Th€:sf gusdp;#ces maker adndLtesid~onfyfof^`&flrfeftydepa[rpcees.

ffig%¥#asfttsfairffi

We st":erslyL¥ ...,, i , rm-H.I

•`--I ....,- t= - H

`.h,. ch£ :.: :.::',:~.,` ;+;}!. <`?,.r:i;:a...'j`?:,i;S+i`: :'w~{`f``..ri'T`-I , ` .-I

afya£;.eshdy:,..fr!ifetiRE,,?.d`: ..-,, ;,. .I.:::t ;-.`.^^ , .

cfty`,fo:-

1),;givife.i

::i.L#O

'

i\` ^` .*

.

`T.,a.:',-i-`;:.,a-S`*¢£€rfe;£i`'`i,h,..,``,.`ae #;;;.:XS.:.

vth\\/

_-, qurfif -i